Nurse Practitioner · East Syracuse, NY
NPI
1023774809
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
115 Creek Cir
East Syracuse, NY, 13057
Phone (315) 413-3375
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$679K
5,244 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jessica L Lokay prescribed most often to Medicare patients was Atorvastatin Calcium, with 253 prescriptions and refills. In total Jessica L Lokay wrote 5,244 Medicare prescriptions that cost $679K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 253 | 253 | 31 | $8,629 |
| Levothyroxine Sodium Generic | 226 | 226 | 23 | $881 |
| Pantoprazole Sodium Generic | 200 | 200 | 19 | $7,358 |
| Metoprolol Succinate Generic | 182 | 182 | 17 | $1,079 |
| Gabapentin Generic | 162 | 162 | 15 | $1,984 |
| Sertraline Hcl Generic | 147 | 147 | 12 | $3,528 |
| Furosemide Generic | 145 | 145 | 14 | $192 |
| Lisinopril Generic | 137 | 137 | Under 11 | $619 |
| Metformin Hcl Generic | 125 | 125 | 13 | $1,302 |
| Amlodipine Besylate Generic | 115 | 115 | 12 | $1,388 |
| Trazodone Hcl Generic | 111 | 111 | Under 11 | $927 |
| Eliquis Apixaban | 109 | 109 | Under 11 | $42K |
| Metoprolol Tartrate Generic | 83 | 83 | Under 11 | $322 |
| Famotidine Generic | 81 | 81 | Under 11 | $1,563 |
| Losartan Potassium Generic | 79 | 79 | Under 11 | $1,029 |
Brand drugs: 840 claims; generic drugs: 4,382 claims; opioid claims: 145.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jessica L Lokay were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.